Post-Marketing Surveillance of Adverse Events Following Recombinant Zoster Vaccine — China, 2020–2023

    FullText(HTML)
  • loading
    • References (15)
    • Related Articles
  • Yan Li, Keli Li, Minrui Ren, Yuan Li, Lina Zhang, Chunxiang Fan, Zhaonan Zhang, Lei Cao, Wenzhou Yu, Zundong Yin. Post-Marketing Surveillance of Adverse Events Following Recombinant Zoster Vaccine — China, 2020–2023J. China CDC Weekly, 2025, 7(17): 574-579. DOI: 10.46234/ccdcw2025.092
    Citation: Yan Li, Keli Li, Minrui Ren, Yuan Li, Lina Zhang, Chunxiang Fan, Zhaonan Zhang, Lei Cao, Wenzhou Yu, Zundong Yin. Post-Marketing Surveillance of Adverse Events Following Recombinant Zoster Vaccine — China, 2020–2023J. China CDC Weekly, 2025, 7(17): 574-579. DOI: 10.46234/ccdcw2025.092
    shu

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return